6 news items
SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in Geographic Atrophy (GA)
APLS
10 Jun 24
that are not historical facts, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. The words
Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN Presented as Late-Breaker at ERA Congress
APLS
24 May 24
, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. The words "anticipate
Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results
APLS
7 May 24
matters that are not historical facts, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act
Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
APLS
1 May 24
of The Private Securities Litigation Reform Act of 1995. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may
Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)
APLS
26 Apr 24
regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform
nrkfs fddoo5wjkwnshka5q6u5kdhhj5mujg
APLS
4 Apr 24
constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include
- Prev
- 1
- Next